FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Macleods Pharmaceuticals Levothyroxine Sodium Tablets Recall

Levothyroxine Sodium Tablets, USP 112 mcg (0

Macleods Pharmaceuticals Ltd

Risk level
Class III
Reported by FDA
Jun 18, 2025
Recall ID
D-0470-2025
Check your lot numberHow we source this data

Summary

Macleods Pharmaceuticals recalled Levothyroxine Sodium Tablets starting May 29, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0470-2025 on Jun 18, 2025. Reason: Presence of a foreign substance: black hair found embedded in tablet. Status: Ongoing.

Why it was recalled

Presence of a foreign substance: black hair found embedded in tablet.

Product description

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Lot numbers, UPCs & expiration codes

Lot #: MLF2401A, Exp 01/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0470-2025
Classification
Class III
Status
Ongoing
Recall initiated
May 29, 2025
FDA report date
Jun 18, 2025
Quantity
1,344- 1000 count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Macleods Pharmaceuticals Ltd

Original FDA data

Every field from FDA enforcement report D-0470-2025, exactly as published.

Show all FDA fields
City
Mumbai
Status
Ongoing
Country
India
Event ID
96979
Address
304 Atlanta Arcade
Address (line 2)
Church Road
Code information
Lot #: MLF2401A, Exp 01/31/2026
Report date
Jun 18, 2025
Product type
Drugs
Recall number
D-0470-2025
Classification
Class III
Recalling firm
Macleods Pharmaceuticals Ltd
Product quantity
1,344- 1000 count bottles
Reason for recall
Presence of a foreign substance: black hair found embedded in tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.
Distribution pattern
Nationwide in the USA
Recall initiation date
May 29, 2025
Initial firm notification
Letter
Center classification date
Jun 12, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0470-2025, published Jun 18, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls